Upmodulation of multinucleated cell formation in long-term human bone marrow cultures by leukaemia inhibitory factor (LIF)

Cytokine

Volumn 9, Issue 1, 1997, Pages 46-52

  Heymann, D ^a   Gouin, F ^a   Guicheux, J ^a   Munevar, J C ^a   Godard, A ^b   Daculsi, G ^a  

^a UNIVERSITÉ DE NANTES   (France)

^b INSTITUT DE BIOLOGIE   (France)

Author keywords

Human bone marrow; Inflammation; Leukaemia inhibitory factor; Monocyte; Polykaryon

Indexed keywords

ACID PHOSPHATASE; ACUTE PHASE PROTEIN; CALCITONIN; CYTOKINE; LEUKEMIA INHIBITORY FACTOR; TARTARIC ACID;

ARTICLE; BONE MARROW CULTURE; CELL LINEAGE; CELL STRUCTURE; CONTROLLED STUDY; DENTIN; DRUG EFFECT; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE; LIVER CELL; MACROPHAGE; MEDIATOR; MONOCYTE; MULTINUCLEAR CELL; OSTEOCLAST; PHAGOCYTOSIS; POLYKARYON; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS;

EID: 0030937874     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0134     Document Type: Article

References (40)

1. 1. Moreau JF, Bonneville M, Peyrat MA, Jacques Y, Soulillou JP (1986) Capacity of alloreactive human clones to produce factor(s) inducing proliferation of the IL-3-dependent DA1 murine cell line. Evidence that this production is under IL-2 control. Ann Inst Pasteur/Immunol 137c:25-37.
2. 2. Anegon I, Moreau JF, Godard A, Jacques Y, Peyrat MA, Hallet MM, Wong G, Soulillou JP (1990) Production of human interleukin for DA cells (HILDA)/leukemia inhibitory factor (LIF) by activated monocytes. Cell Immunol 130:50-65.
3. 3. Miyagi T, Akashi M, Yamato K, Mioshy I, Koeffler HP (1991) D-factor: modulation of expression in fibroblasts. Leukemia Res 15:441-451.
4. 4. Wetzler M, Talpaz M, Lowe DG, Baiocchi, Gutterman JU, Kurzrock R (1991) Constitutive expression of leukemia inhibitory factor RNA by human bone marrow stromal cells and modulation by IL-1, TNF-α and TGF-β. Exp Hematol 19:347-351.
5. 5. Gascan H, Anegon I, Praloran V, Naulet J, Godard A, Soulillou JP, Jacques Y (1990) Constitutive production of human interleukin for Da cells/leukemia inhibitory factor by human tumor cell lines derived from various tissues. J Immunol 144:2592-2598.
6. 6. Tomida M, Yamamoto-Yamaguchi Y, Hozumi M (1984) Purification of a factor inducing differentiation of mouse myeloid leukemia M1 cells from conditioned medium of mouse fibroblast L929 cells. J Biol Chem 259:10978-10982.
7. 7. Smith AG, Heath JK, Donaldson DD, Wong GG, Moreau JF, Stahl M, Rogers D (1988) Inhibition of pluripotential stem cell differentiation by purified polypeptides. Nature 336:688-690.
8. 8. Yamamori T, Fukada D, Hebersold R, Korshing S, Fann MJ, Patterson PH (1989) The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor. Science 246:1412-1416.
9. 9. Heymann D, Godard A, Raher S, Ringeard S, Lassort D, Blanchard F, Harb J (1995) Human interleukin for Da cells/leukemia inhibitory factor and Oncostatin M enhance membrane expression of intercellular adhesion molecule-1 on melanoma cells but not the shedding of its soluble form. Cytokine 7:111-117.
10. 10. Heymann D, Harb J, Ringeard S, Blanchard F, Lassort D, Godard A (1995) Upmodulation of ανβ1 integrin expression on human tumor cells by human interleukin for DA cells/leukemia inhibitory factor and Oncostatin M. Correlation with increased cell adhesion on fibronectin. J Cell Biochem 58:305-314.
11. 11. Rose TM, Bruce AG (1991) Oncostatin M is a member of a cytokine family which includes leukemia inhibitory and interleukin-6 Proc Natl Acad Sci USA 88:8641-8645.
12. 12. Baumann HH, Wong GG (1989) Hepatocyte-stimulating factor III shares structural and functional identity with leukemia-inhibitory factor. J Biol Chem 143:1163-1167.
13. 13. Baumann H, Ziegler SF, Mosley B, Morella KK, Pajovic S, Gearing DP (1993) Reconstitution of the response to leukemia inhibitory factor, Oncostatin M, ciliary neurotrophic factor in hepatoma cells. J Biol Chem 268:8414-8417.
14. 14. Schooltink H, Stoyan T, Roeb E, Heinrich PC, Rose-John S (1992) Ciliary neurotrophic factor induces acute-phase protein expression in hepatocytes. FEBS Lett 314:280-284.
15. 15. Gearing DP, Comeau MR, Frienf DJ, Gimpel SD, Thut CJ, McGourty J, Brasher KK, King JA, Gillis S, Mosley B, Ziegler SF, Cosman D (1992) The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science 255:1434-1437.
16. 16. Godard A, Heymann D, Raher S, Anegon I, Peyrat MA, Le Mauff B, Mouray E, Gregoire M, Virdee K, Soulillou JP, Moreau JF, Jacques Y (1992) High and low affinity receptors for human interleukin for DA cells/leukemia inhibitory factor on human cells. Molecular characterization and cellular distribution. J Biol Chem 267:3214-3222.
17. 17. Davis S, Aldrich TH, Sthal N, Pan L, Taga T, Kishimoto T, Ip NY, Yancopoulos GD (1993) LIFRβ and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. Science 260:1805-1808.
18. 18. Lübbert M, Mantovani L, Lindermann A, Mertelsmann R, Hermann F (1991) Expression of leukemia inhibitory factor is regulated in human mesenchymal cells. Leukemia 5:361-365.
19. 19. Hamilton JA, Waring PM, Filonzi EL (1993) Induction of leukemia inhibitory factor in human synovial fibroblasts by IL-1 and tumor necrosis factor-a. J Immunol 150:1496-1502.
20. 20. Wetzler M, Talpaz M, Lowe DG, Baiocchi G, Gutterman JU, Kurzrock R (1991) Constitutive expression of leukemia inhibitory factor RNA by human bone marrow stromal cells and modulation by IL-1 TNF-α and TGF-β Exp Hematol 19:347-351.
21. 21. Lotz M, Moats T, Villiger PM (1992) Leukemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis. J Clin Invest 90:888-896.
22. 22. Dechanet J, Taupin JL, Chomarat P, Rissoan MC, Moreau JF, Banchereau J, Miossec P (1994) Interleukin-4 but not interleukin-10 inhibits the production of leukemia inhibitory factor by rheumatoid synovium and synoviocytes. Eur J Immunol 24:3222-3228.
23. 23. Brown MA, Metcalf D, Gough NM (1994) Leukaemia inhibitory factor and interleukin 6 are expressed at very low levels in the normal adult mouse and are induced by inflammation. Cytokine 6:300-309.
24. 24. Suda, Takahashi N, Martin TJ (1995) Modulation of osteoclast differentiation: update. Endocrine Rev 4:266-270.
25. 25. MacDonald BR, Takahashi N, McManus LM, Holahan J, Mundy GR, Roodman GD (1987) Formation of multinucleated cells that respond to osteotropic hormones in long-term human bone marrow cultures. Endocrinology 120:2326-2333.
26. 26. Baumann HH, Gauldie J (1994) The acute phase response. Immunol Today 15:74-88.
27. 27. Waring P, Wycherley K, Nicola N, Metcalf D (1992) Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids. J Clin Invest 90:2031-2037.
28. 28. Waring PM, Romero R, Laham N, Gomez R, Rice GE (1994) Leukemia inhibitory factor: association with intraamniotic infection. Am J Obstet Gynecol 171:1331-1341.
29. 29. Waring PM, Carroll GJ, Kandiah DA, Buirski G, Metcalf D (1993) Increased levels of leukemia inhibitory factor in synovial fluid from patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 36:911-915.
30. 30. Villers D, Dao T, Nguyen JM, Bironneau E, Godard A, Moreau M, De Groote D, Nicolas F, Soulillou JP, Anegon I (1995) Increased plasma levels of human interleukin for DA1.a cells/ leukemia inhibitory factor in sepsis correlate with shock and poor prognosis. J Infect Dis 171:232-236.
31. 31. Waring PM, Waring LJ, Metcalf D (1994) Circulating leukemia inhibitory factor levels correlate with disease severity in meningococcemia. J Infect Diseases 170:1224-1228.
32. 32. Heymann D, L'Her E, Nguyen JM, Raher S, Canfrère I, Coupey L, Fixe P, Chailleux E, De Groote D, Praloran P, Godard A (1996) Leukemia inhibitory factor (LIF) production in pleural effusions; comparison with production of interleukin(s)-4, -8, -10 and macrophage-colony stimulating factor (M-CSF). Cytokine, 8:410-416.
33. 33. Hilton DJ, Nicola NA, Metcalf D (1991) Distribution and comparison of receptors for LIF on murine hemopoietic and hepatic cells. J Cell Physiol 146:207-215.
34. 34. Carroll GJ, Bell MC, Chapman HM, Mills JN, Robinson WF (1995) Leukemia inhibitory factor induces leukocyte infiltration and cartilage proteoglycan degradation in goat joints. J Interferon Cytokine Res 15:567-573.
35. 35. Suda T, Takahashi N, Martin TJ (1992) Modulation of osteoclast differentiation. Endocrine Rev 13:66-80.
36. 36. Lecron JC, Roblot P, Chevalier S, Morel F, Alderman E, Gombert J, Gascan H (1993) High circulating leukaemia inhibitory factor (LIF) in patients with giant cell arteritis: independent regulation of LIF and IL-6 under corticosteroid therapy. Clin Exp Immunol 92:23-26.
37. 37. Pepper MS, Ferrara N, Orci L, Montesano R (1995) Leukemia inhibitory factor (LIF) inhibits angiogenesis in vitro. J Cell Sci 108:73-83.
38. 38. Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, Koishihara Y, Ohsugi, Jumaki K, Taga T, Kishimoto T, Suda T (1993) Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci USA 90:11924-11928.
39. 39. Soueidan A, Gan OI, Gouin F, Godard A, Heymann D, Jacques Y, Daculsi G (1995) Culturing of cells from giant cell tumour of bone on natural and synthetic calcified substrata: the effect of leukaemia inhibitory factor and vitamin D3 on the resorbing activity of osteoclast-like cells. Virchows Arch 426:469-477.
40. 40. Grano M, Colucci S, De Bellis M, Zigrino P, Argentino, Zambonin G, Serra M, Scotlandi K, Teti A, Zambonin Zallone A (1994) New model for bone resorption study in vitro: human osteoclast-like cells from giant cell tumors of bone. J Bone Miner Res 9:1013-1020.